Rozasea’nın komorbiditeleri

Yıl 2021, Cilt: 2 Sayı: 1, 21 - 24, 30.03.2021

Sevilay Kılıç

Öz

Comorbidities of rosacea

Öz

Objective: Rosacea is a common chronic, inflammatory skin disease and some comorbid diseases often accompany the disease. We evaluated the relationship between rosacea and systemic comorbidities in our study.
Materyals and Methods: Our study is a retrospective descriptive study. From XXXXXXXUniversity Medical Faculty Hospital's patient information system, 18 years and older aged, a total of 114 adult patients who were diagnosed with rosacea with at least 2-3 months of follow-up in the period between 2012-2018 were included in the study.
Results: Of the 114 patients included in the study, 76.3% (n = 87) were female and 23.7% (n = 27) were male. The mean age of the patients was 46.5 ± 10.9 years, the median age was 45.0 years (min: 21.0- max: 72.0). Hypertension 19.3% (22), gastroesophageal / dyspepsia 14.9% (17), hyperlipidemia 13.2% (15), diabetes mellitus 13.2% (15), hypothyroidi 10.8% (12), obesity 9.6% (11) and depression 9% (10) were found to be the most frequently related to such diseases in our rosacea patients.
Conclusion: Rosacea can be easily diagnosed by dermatological examination. And it may be a clue to dermatologists in screening of comorbid diseases related to rosacea.

Anahtar Kelimeler

Rosecea, comorbidity, inflamation, hypertension, dyspepsia, hyperlipidemia

Kaynakça

• 1. McAleer MA, Lacey N, Powell FC. The pathophysiology of rosacea. G Ital Dermatol Venereol 2009; 144:663.
• 2. Buhl T, Sulk M, Nowak P, et al. Molecular and morphological characterization of inflammatory infiltrate in rosacea reveal sactivation of Th1/Th17 pathways. J Invest Dermatol 2015;135:2198-208.
• 3. Two AM, Wu W, Gallo RL, et al. Rosacea. Part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol 2015;72:749-58.
• 4. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and sub type classification. J AmAcadDermatol. 2004; 51:327.
• 5. Egeberg A, Weinstock LB, Thyssen EP, et al. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol 2017; 176:100-6.
• 6. N. Duman, S. Ersoy Evans, N. Atakan. Rosacea and cardiovascular risk factors: a case control study. J Eur Acad Dermatol Venereol 2014;28(9):1165-9
• 7. Haber R, El Gemayel M. Comorbidities in rosacea: A systematic review and update. J Am Acad Dermatol. 2018;78(4):786-792.e8.
• 8. P. Libby. Inflammation in atherosclerosis. Nature. 2002;19-26;420:868-74.
• 9. N.N. Mehta, R.S. Azfar, D.B. Shin, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010; 31(8): 1000–06.
• 10. Z. Takci, S.G. Bilgili, Karadag AS, et al. Decreased serum paraoxonae and arylesterase activities in patients with rosacea. J EurAcad Dermatol Venerseol. 2015;29(2):367-70.
• 11. W.C. Watson, E. Paton, D. Murray. Small-bowel disease in rosacea. Lancet. 1965;10;1(7402):47-50.
• 12. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes 2012;3;2:e54.
• 13. Hossler EW, Maroon MS, Mowad CM. Gastric bypass surgery improves psoriasis. J Am Acad Dermatol. 2011; 65(1):198-200.
• 14. Gerdes S, Rostami-Yazdi M, Mrowietz U. Adipokines and psoriasis. ExpDermatol. 2011; 20(2):81-7.
• 15. Gravina A, Federico A, Ruocco E, et al..Helicobacterpylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United European Gastroenterol J. 2015;3(1):17-24.
• 16. Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial over growth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol 2008; 6(7):759-64.
• 17. Egeberg A, Hansen PR, Gislason GH, et al. Clustering of autoimmunediseases in patientswithrosacea. J Am Acad Dermatol. 2016;74(4):667-72.e1.
• 18. P.A. McCombe, J.M. Greer, I.R. Mackay. Sexual dimorphism in autoimmune disease. CurrMol Med.2009;9(9):1058-79.
• 19. A.L. Chang, I. Raber, J. Xu, et al. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol.2015;135(6):1548-55.
• 20. J. Spoendlin, J.J. Voegel, S.S. Jick, Meier CR. Risk of rosacea in patients with diabetes using insülin or oral antidiabetic drugs. J Invest Dermatol.2013;133(12):2790-93.
• 21. M.A. Gupta A.K. Gupta S.J. Chen A.M. Johnson. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory CareSurvey—Outpatient Department data collected by the U.S. National Center for Health Statistic from 1995 to 2002. British Journal of Dermatology. 2005;153(6):1176-81.
• 22. Boehncke WH, Ochsendorf F, Paeslack I, et al. Decorative cosmetic simprove the quality of life in patientswith disfiguring skin diseases. Eur J Dermatol. 2002;12:577-80.
• 23. Maes M: Depression is an inflammatorydisease, but cell-mediated immuneactivation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:664-75.
• 24. Garvin P, Nilsson L, Carstensen J, et al. Plasma levels of matrix metalloproteinase-9 are independently associated with psychosocial factors in a middle-aged normal population. Psychosom Med. 2009;71:292-300.
• 25. Kimball AB, Wu Y. Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. Int J Dermatol. 2009;48(11):1147-56.